z-logo
open-access-imgOpen Access
To the question of the use of alimamazine (Teraligen®) in patients with atopic dermatitis in combination with anxiety-depressive disorder
Author(s) -
A. S. Edin
Publication year - 2018
Publication title -
consilium medicum
Language(s) - English
Resource type - Journals
eISSN - 2542-2170
pISSN - 2075-1753
DOI - 10.26442/2075-1753_2018.2.145-150
Subject(s) - atopic dermatitis , anxiety , dermatology , depressive symptoms , major depressive disorder , medicine , clinical psychology , psychiatry , psychology , mood

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom